Comparison Of Blue Light Filter Feature and Blue Blocking Lenses in Digital Device Users With Dry Eye Patients

Comparing Blue Light Filter feature and Blue Blocking Lenses for Dry Eye Patients Prolonged screen time can exacerbate dry eye symptoms.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Key information

Conditions

Dry Eye Syndromes Eye Diseases Lacrimal Apparatus Diseases

Age range

12 year–34 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Khursheed baigam eye hospital raiwind road manga mandi

Lahore, Punjab Province, Pakistan

About this study

Two solutions, blue light filter software and blue blocking lenses, aim to reduce eye strain. Blue light filter software adjusts screen color temperatures, reducing blue light emission. Blue blocking lenses provide a physical barrier, blocking blue light from reaching the eyes.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Adults aged 12-34
Spend at least 4 hours per day on digital devices.
Experience dry eye symptoms.
Willing to participate in the study and provide informed consent.

Exclusion criteria

Pre-existing eye conditions (e.g., cataracts, glaucoma).
Wear contact lenses.
Have undergone eye surgery.
Are pregnant or breastfeeding.

Treatment and study plan

Blue cut filter

Diagnostic Test

Group 1 will be prescribe with blue cut filter feature

blue cut glasses

Diagnostic Test

Group 2 will be prescribed with blue cut glasses

Primary outcomes

The Ocular Surface Disease Index (OSDI)

Time frame: 12 Months

The Ocular Surface Disease Index (OSDI) is a 12-question questionnaire used to assess the severity of dry eye symptoms and their impact on vision-related function, scored on a scale of 0 to 100, with higher scores indicating greater disability

Sponsors and collaborators

Lead sponsor

Superior University

Other

Registry information

Important dates

Study start: 2025
Primary completion: 2025
Study completion: 2026
First posted: Apr 6, 2025
Registry last updated: Apr 6, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Active, Not Recruiting